Company

OverT

Rocket Ship Rating

Rocket Ship Rating: 94 out of 100

OverT is redefining what's possible with programmed, off-the-shelf cell therapies and biologics.

Also known as OverT Bio, OverT Bio, Inc.

Biotech & therapeutics
Deeptech

Status: Operatingas of 2026-09-17
Business model: B2B
Headquarters: New York, NY, United States
Legal name: OverT Bio, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

OverT Bio is pioneering next-generation cell therapy and biologics to overcome the toughest challenges in solid tumors.

Funding snapshot

Total raised: $16.1MSum of rounds, as of 2026-09-17Source (opens in a new tab)
Latest round: Undisclosed, $16M2024-05-06

Funding rounds

Round, 2024: $16M2024-05-06, Company stated
Grant: $120K2023-11-22, Company stated
Round, 2023: $16M2023-04-04, SEC form D sold, 15 investors

Products

Other: OVT-101
Web: OVT-101
Other: OVT-201
Web: OVT-201